Cigna Group (CI) Financial Statements (2026 and earlier)

Company Profile

Business Address 900 COTTAGE GROVE ROAD
BLOOMFIELD, CT 06002
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 6324 - Hospital and Medical Service Plans (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

12/31/2025
Q4
9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6,9085,1429,0618,2156,7527,856
Cash and cash equivalent6,0254,3298,3347,5505,8886,788
Short-term investments8838137276658641,068
Receivables31,70931,14826,92924,22727,84625,111
Inventory, net of allowances, customer advances and progress billings5,6325,9675,1766,6925,0835,173
Inventory5,6325,9675,1766,6925,0835,173
Disposal group, including discontinued operation    7,0046,8745,411
Other current assets2,4862,4662,3892,7322,6672,664
Total current assets:46,73544,72343,55548,87049,22246,215
Noncurrent Assets
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization      
Long-term investments and receivables18,48315,66215,35015,12815,27015,944
Long-term investments18,48315,66215,35015,12815,27015,944
Intangible asset, including goodwill, after accumulated amortization73,89973,04673,41773,78774,16574,434
Goodwill44,92444,37544,37244,37044,37444,258
Intangible asset, excluding goodwill, after accumulated amortization28,97528,67129,04529,41729,79130,176
Other noncurrent assets3,3892,9293,0032,7863,1803,276
Other undisclosed noncurrent assets15,41315,29115,33315,31015,80215,577
Total noncurrent assets:111,184106,928107,103107,011108,417109,231
TOTAL ASSETS:157,919151,651150,658155,881157,639155,446
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9,3469,9389,1369,2948,5159,275
Accounts payable9,3469,9389,1369,2948,5159,275
Debt3,0934,2883,9933,0352,5721,717
Disposal group, including discontinued operation    2,4102,7752,259
Other undisclosed current liabilities44,01442,55342,61643,24043,19842,122
Total current liabilities:56,45356,77955,74557,97957,06055,373
Noncurrent Liabilities
Long-term debt and lease obligation, including:30,94726,48026,45528,93730,23030,175
Long-term debt, excluding current maturities    415052
Finance lease, liability      
Other undisclosed long-term debt and lease obligation30,94726,48026,45528,89630,18030,123
Liabilities, other than long-term debt10,87010,43210,45810,1909,82710,491
Deferred income tax liabilities6,9976,7816,8796,9756,7946,953
Other liabilities3,8733,6513,5793,2153,0333,538
Other undisclosed noncurrent liabilities17,63517,53017,58617,53218,22417,880
Total noncurrent liabilities:59,45254,44254,49956,65958,28158,546
Total liabilities:115,905111,221110,244114,638115,341113,919
Equity
Equity, attributable to parent41,80540,21440,22641,03342,09541,332
Common stock444444
Treasury stock, value(34,126)(34,126)(33,065)(31,437)(29,412)(29,410)
Additional paid in capital31,69831,58831,44331,28831,18631,048
Accumulated other comprehensive loss(2,799)(2,816)(2,590)(2,341)(2,163)(2,442)
Retained earnings47,02845,56444,43443,51942,48042,132
Equity, attributable to noncontrolling interest209216188210203195
Total equity:42,01440,43040,41441,24342,29841,527
TOTAL LIABILITIES AND EQUITY:157,919151,651150,658155,881157,639155,446

Income Statement (P&L) ($ in millions)

12/31/2025
Q4
9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
Revenues69,74867,17865,50265,64963,69460,523
Premiums earned, net9,0819,15612,73611,50311,43611,454
Cost of revenue(63,372)(61,017)(58,896)(59,187)(57,092)(54,007)
Cost of product and service sold(55,530)(53,268)(48,398)(49,021)(47,565)(44,492)
Policyholder benefits and claims incurred, net(7,842)(7,749)(10,498)(10,166)(9,527)(9,515)
Gross profit:6,3766,1616,6066,4626,6026,516
Operating expenses(3,798)(3,855)(4,635)(4,289)(4,026)(4,104)
Operating income:2,5782,3061,9712,1732,5762,412
Nonoperating expense
(Other Nonoperating expense)
(347)(337)(362)(362)(376)(375)
Interest and debt expense(363)(338)(362)(400)(380)(378)
Income from continuing operations before equity method investments, income taxes:1,8681,6311,2471,4111,8201,659
Other undisclosed income (loss) from continuing operations before income taxes427390401598(628)330
Income from continuing operations before income taxes:2,2952,0211,6482,0091,1921,989
Income tax expense(322)(389)(239)(473)(367)(360)
Net income:1,9731,6321,4091,5368251,629
Net loss attributable to noncontrolling interest(105)(100)(86)(112)(86)(81)
Net income available to common stockholders, diluted:1,8681,5321,3231,4247391,548

Comprehensive Income ($ in millions)

12/31/2025
Q4
9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
Net income:1,9731,6321,4091,5368251,629
Other comprehensive income (loss)17(226)(249)(178)279(118)
Comprehensive income:1,9901,4061,1601,3581,1041,511
Comprehensive loss, net of tax, attributable to noncontrolling interest(105)(100)(86)(112)(86)(81)
Comprehensive income, net of tax, attributable to parent:1,8851,3061,0741,2461,0181,430

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: